609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation

Keywords : NCT02945033
Type de document :
Communication dans un congrès
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. 28 (suppl_5), 2017, Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8–12 September 2017, Madrid, Spain. 〈https://academic.oup.com/annonc/article/28/suppl_5/mdx393.134/4109906〉. 〈10.1093/annonc/mdx393.134〉
Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01632463
Contributeur : Lnc - Université de Bourgogne <>
Soumis le : vendredi 10 novembre 2017 - 11:28:27
Dernière modification le : lundi 26 novembre 2018 - 10:50:05

Lien texte intégral

Identifiants

Citation

P. Michel, T. André, V. Boige, T. Aparicio, E. Maillard, et al.. 609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation. the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. 28 (suppl_5), 2017, Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8–12 September 2017, Madrid, Spain. 〈https://academic.oup.com/annonc/article/28/suppl_5/mdx393.134/4109906〉. 〈10.1093/annonc/mdx393.134〉. 〈hal-01632463〉

Partager

Métriques

Consultations de la notice

107